Bruce K. Patterson
Incell Corporation (United States)
ORCID: 0000-0001-9793-9986Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 4 papers. Top paper: “CCR5 inhibition in critical COVID-19 patients decreases inflammatory cytokines, increases CD8 T-cells, and decreases SARS-CoV2 RNA in plasma by day 14”.
Harish Seethamraju, Kush Dhody, Michael J. Corley, Kazem Kazempour, Jay Lalezari +25 more
Alina P.S. Pang, Kush Dody, Philip A. Mudd, Bruce K. Patterson, Harish Seethamraju +14 more
Aaron Day, Wafaa B. Alsoussi, Zhuoming Liu, Jane A. O’Halloran, Rachel M. Presti +5 more
Gabriela M. Webb, Helen L. Wu, Justin Greene, Shaheed Abdulhaqq, Katherine B. Bateman +28 more